Triumph Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Triumph Capital Management's AMGN Position: Q3 2026 in Review
Triumph Capital Management increased its Amgen (AMGN) stake by 0.73% in Q3 2026, buying an estimated $4.78K and bringing the position to 1,656 shares worth $698K. The position accounts for 0.12% of the portfolio, ranked #181.
Triumph Capital Management first reported a position in AMGN in Q2 2021 and has held it in 9 quarters since. 3,272 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Triumph Capital Management held 1,656 shares of Amgen worth $698K as of Q3 2026.
- Triumph Capital Management bought 12 Amgen shares in Q3 2026, an estimated $4.78K.
- Amgen made up 0.12% of Triumph Capital Management's portfolio in Q3 2026, its #181 holding.
- Triumph Capital Management first reported a position in Amgen in Q2 2021 and has held it in 9 quarters since.
- 3,272 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.